KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Inventory: 2018-2024

Historic Change in Inventory for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Dec 2024 value amounting to -$764,000.

  • Rigel Pharmaceuticals' Change in Inventory rose 94.38% to -$188,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 453.36%. This contributed to the annual value of -$764,000 for FY2024, which is 34.81% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Change in Inventory stood at -$764,000 for FY2024, which was up 34.81% from -$1.2 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Change in Inventory registered a high of $4.9 million during FY2021, and its lowest value of -$1.2 million during FY2023.
  • For the 3-year period, Rigel Pharmaceuticals' Change in Inventory averaged around $147,000, with its median value being -$764,000 (2024).
  • In the last 5 years, Rigel Pharmaceuticals' Change in Inventory surged by 3,769.05% in 2021 and then slumped by 149.31% in 2023.
  • Over the past 5 years, Rigel Pharmaceuticals' Change in Inventory (Yearly) stood at $126,000 in 2020, then surged by 3,769.05% to $4.9 million in 2021, then tumbled by 51.24% to $2.4 million in 2022, then slumped by 149.31% to -$1.2 million in 2023, then spiked by 34.81% to -$764,000 in 2024.